TAZENTA 2MG INJ is a Schedule H drug. TAZENTA 2MG INJ is composed of: BORTEZOMIB (2.0 MG)
Tag: medicine for mantle cell lymphoma
PROTEOZ 2MG INJ
PROTEOZ 2MG INJ is a Schedule H drug. PROTEOZ 2MG INJ is composed of: BORTEZOMIB (2.0 MG)
ORTEZ 2MG INJ
ORTEZ 2MG INJ is a Schedule H drug. ORTEZ 2MG INJ is composed of: BORTEZOMIB (2.0 MG)
MYEZOM 3.5MG INJ
MYEZOM 3.5MG INJ is a Schedule H drug. MYEZOM 3.5MG INJ is composed of: BORTEZOMIB (3.5 MG)
LENZEST 25MG CAP
LENZEST 25MG CAP is a Schedule H drug. LENZEST 25MG CAP is composed of: LENALIDOMIDE (25.0 MG)
LENZEST 10MG CAP
LENZEST 10MG CAP is a Schedule H drug. LENZEST 10MG CAP is composed of: LENALIDOMIDE (10.0 MG)
LENOMUST 5MG CAP
LENOMUST 5MG CAP is a Schedule H drug. LENOMUST 5MG CAP is composed of: LENALIDOMIDE (5.0 MG)
LENOMUST 25MG CAP
LENOMUST 25MG CAP is a Schedule H drug. LENOMUST 25MG CAP is composed of: LENALIDOMIDE (25.0 MG)
LENOMUST 10MG CAP
LENOMUST 10MG CAP is a Schedule H drug. LENOMUST 10MG CAP is composed of: LENALIDOMIDE (10.0 MG)
LENOME CAP
LENOME CAP is a Schedule H drug. LENOME CAP is composed of: LENALIDOMIDE (10.0 MG)